We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Sensor Detects Antibodies to Gliadin, a Component of Gluten

By LabMedica International staff writers
Posted on 19 Nov 2008
Scientists in Spain and the United Kingdom have developed a fast test for identifying the food protein that triggers celiac disease, a difficult-to-diagnose digestive disease involving the inability to digest a protein called gluten that is present in wheat, oats, rye, and barley. More...
They have developed an electrochemical immunosensor that detects antibodies to the protein gliadin, which is a component of gluten.

The standard test for gliadin is an enzyme-linked immunosorbant assay (ELISA). The test using the new immunosensor took barely 90 minutes to detect gliadin in the parts per billion range compared to eight hours for the ELISA. Both tests were equally accurate but the new sensor would be easier to use at food manufacturing plants, the scientists note.

Avoiding food that contains gluten can be difficult for patients with celiac disease because gluten may be a hidden ingredient in unsuspected foods, such as soy sauce, canned soups, and licorice candy. Some prepared foods list gluten content on package labels, but identifying its presence is difficult and time-consuming.

The sensor could help millions of people avoid diarrhea, bloating, and other symptoms that occur when they unknowingly eat foods containing gluten.

The study was performed by Alex Fragoso, Ph.D. and Ciara O'Sullivan from the Universitat Rovirai I Virgili (Tarragona, Spain) and Kings College London (U.K), together with colleagues in Spain. It appeared in the online edition of Analytical Chemistry (American Society of Chemistry) on October 29, 2008.

Related Links:
Universitat Rovirai I Virgili
Kings College London


Gold Member
STI Test
Vivalytic MG, MH, UP/UU
Online QC Software
Acusera 24•7
Rapid Sepsis Test
SeptiCyte RAPID
Pipette Calibration System
Artel PCS®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Microbiology

view channel
Image: The study compares rapid molecular CPE diagnostics, which can return results in about one hour, with culture-based screening, which typically takes about 48 hours (Image credit: Adobe Stock)

Rapid Molecular Screening Aims to Accelerate Hospital Infection Control for CPE

Drug-resistant infections remain a critical patient-safety threat in hospitals, with carbapenemase-producing Enterobacterales (CPE) among the most urgent concerns. In England, reports of acquired carbapenemase... Read more

Pathology

view channel
Image: The VENTANA PTEN (SP218) RxDx Assay is a qualitative IHC assay for assessing PTEN protein in prostate adenocarcinoma, with staining performed using the OptiView DAB IHC Detection Kit on a BenchMark ULTRA instrument (Photo courtesy of Roche)

New Companion Diagnostic Expands Precision Medicine in Prostate Cancer

Prostate cancer is a leading cancer diagnosis in men and becomes particularly aggressive when it presents as metastatic, hormone-sensitive disease. Tumors with loss of phosphatase and tensin homolog (PTEN)... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.